Thông tin tài liệu:
Table 103-4 Risk Stratification for Idiopathic MyelofibrosisA. Prognostic factorsaHemoglobin 30,000/µLNumber of prognostic factorsRisk groupMedian survival (months)0Low931–2High17B. Prognostic factorsbHemoglobin 1%Number of prognostic factorsRisk groupMedian survival (months)0–1Low992–3High21C. factorscPrognosticMedian survival (months)Age 10 gm%Karyotype: Normal180Abnormal72Age 65 yearsHemoglobin ≤10 gm%Karyotype: Normal44Abnormal16Age 65 yearsHemoglobin 10 gm%Karyotype: Normal70Abnormal78aFrom B Dupriez et al. Blood 88:1013, 1996.bFrom F Cervantes et al. Br J Haematol 102:684, 1998. ...
Nội dung trích xuất từ tài liệu:
Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 7) Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 7) Table 103-4 Risk Stratification for Idiopathic Myelofibrosis A. Prognostic factorsa Hemoglobin 30,000/µL Number of prognostic Risk group Median survivalfactors (months) 0 Low 93 1–2 High 17 B. Prognostic factorsb Hemoglobin < 10 gm% Constitutionalsymptoms Blast cells > 1% Number of prognostic Risk group Median survivalfactors (months) 0–1 Low 99 2–3 High 21 C. Prognostic Median survivalfactorsc (months) Age 65 yearsHemoglobin ≤10 gm%Karyotype: Normal 44 Abnormal 16Age >65 yearsHemoglobin >10 gm%Karyotype: Normal 70 Abnormal 78a From B Dupriez et al. Blood 88:1013, 1996.b From F Cervantes et al. Br J Haematol 102:684, 1998.cFrom JT Reilly et al. Br J Haematol 98:96, 1997.